Stock listing
B1Q Stock Price, News, Filings & Events — Nrx Pharmaceuticals, Inc.
Selected listing: B1Q · TRADEGATE · EUR · DE
This page tracks Nrx Pharmaceuticals, Inc.'s B1Q:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following B1Q:TRADEGATE. B1Q:TRADEGATE is the stock-level entry point for investors researching Nrx Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nrx Pharmaceuticals, Inc. (ticker: NRXP) is a public company operating in the American market, with a market capitalization of approximately $157.3 million. The company focuses on developing innovative therapies to address unmet medical needs. Nrx Pharmaceuticals aims to advance its pipeline and contribute to the healthcare sector through its research and development efforts.
- Ticker
- B1Q:TRADEGATE
- Asset type
- Stock
- Market cap
- $153.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Nrx Pharmaceuticals, Inc. B1Q:TRADEGATE stock context
This page tracks Nrx Pharmaceuticals, Inc.'s B1Q:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following B1Q:TRADEGATE. B1Q:TRADEGATE is the stock-level entry point for investors researching Nrx Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nrx Pharmaceuticals, Inc. (ticker: NRXP) is a public company operating in the American market, with a market capitalization of approximately $157.3 million. The company focuses on developing innovative therapies to address unmet medical needs. Nrx Pharmaceuticals aims to advance its pipeline and contribute to the healthcare sector through its research and development efforts.
Latest news from Nrx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
August 7, 2026
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
June 25, 2026
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcrani...
June 22, 2026
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters O...
June 5, 2026
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ ...
June 4, 2026
Nrx Pharmaceuticals, Inc. earnings calls
NRX Pharmaceuticals, Inc. (NRXP) Q2 2026 Earnings Call
August 17, 2026 · Replay with transcript and chapters
NRX Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call
May 18, 2026 · Replay with transcript and chapters
NRX Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call
March 24, 2026 · Replay with transcript and chapters
NRX Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call
November 17, 2025 · Replay with transcript and chapters
NRX Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call
August 20, 2025 · Replay with transcript and chapters
NRX Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Nrx Pharmaceuticals, Inc.
Nrx Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for B1Q:TRADEGATE.
Nrx Pharmaceuticals, Inc. company profile
View the public company page for Nrx Pharmaceuticals, Inc. on 6ix.
Nrx Pharmaceuticals, Inc. news
Read company news and market updates connected to Nrx Pharmaceuticals, Inc..
Nrx Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Nrx Pharmaceuticals, Inc..
Alternate listings
NRXP:NASDAQ
US · USD
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
A4091K:LSX
DE · EUR
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
A4091K:LS
DE · EUR
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
NRXP:BOATS
US · USD
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
B1Q:GETTEX
DE · EUR
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
B1Q:FWB
DE · EUR
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
B1Q:HAM
DE · EUR
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.
B1Q:MUN
DE · EUR
Alternate listing for Nrx Pharmaceuticals, Inc.; the primary context on this page is B1Q:TRADEGATE.